1. Home
  2. LAB vs KMDA Comparison

LAB vs KMDA Comparison

Compare LAB & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Standard BioTools Inc.

LAB

Standard BioTools Inc.

HOLD

Current Price

$0.98

Market Cap

354.1M

Sector

Industrials

ML Signal

HOLD

Logo Kamada Ltd.

KMDA

Kamada Ltd.

HOLD

Current Price

$8.37

Market Cap

488.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LAB
KMDA
Founded
1999
1990
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
354.1M
488.6M
IPO Year
2008
2013

Fundamental Metrics

Financial Performance
Metric
LAB
KMDA
Price
$0.98
$8.37
Analyst Decision
Hold
Strong Buy
Analyst Count
1
2
Target Price
$1.35
$14.00
AVG Volume (30 Days)
2.4M
56.4K
Earning Date
05-05-2026
05-13-2026
Dividend Yield
N/A
2.97%
EPS Growth
61.54
N/A
EPS
N/A
N/A
Revenue
$101,937,000.00
N/A
Revenue This Year
N/A
$13.94
Revenue Next Year
$2.63
$9.84
P/E Ratio
N/A
$24.59
Revenue Growth
N/A
N/A
52 Week Low
$0.87
$6.35
52 Week High
$1.72
$9.35

Technical Indicators

Market Signals
Indicator
LAB
KMDA
Relative Strength Index (RSI) 52.37 47.88
Support Level $0.92 $8.38
Resistance Level $1.01 $8.88
Average True Range (ATR) 0.05 0.19
MACD 0.01 0.02
Stochastic Oscillator 88.90 68.25

Price Performance

Historical Comparison
LAB
KMDA

About LAB Standard BioTools Inc.

Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

Share on Social Networks: